Singapore Pharmaceuticals and Healthcare - Report Q4 2014

Business Monitor International
September 3, 2014
129 Pages - SKU: BMI5321336
Countries covered: Singapore

Singapore Pharmaceuticals and Healthcare - Report Q4 2014

BMI View: While Singapore's small population will limit the pharmaceutical market's overall growthpotential, the government's commitment to healthcare as well as the ageing population will boostconsumption of pharmaceuticals over the long term. In addition, the impending launch of the Association ofSouth East Asian Nations Community in 2015 will increase Singapore's attractiveness to foreignpharmaceutical firms.

Headline Expenditure Projections

Pharmaceuticals: SGD990mn (USD790mn) in 2013 to SGD1.04bn (USD830mn) in 2014; +5.5% inlocal currency terms and +5.0% in US dollar terms. Forecast unchanged from Q314.

Healthcare: SGD17.78bn (USD14.21bn) in 2013 to SGD19.33bn (USD15.38bn) in 2014; +8.7% in localcurrency terms and +8.3% in US dollar terms. Forecast slightly downgraded from Q314.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014BMI View: We expect Uzbekistan's healthcare spending to continue outpacing the country's economicgrowth, creating opportunities for most health ...
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014BMI View: The UAE continues to appeal to businesses thanks to its growing economy, which willincreasingly ...
Pharmaceuticals and Healthcare Report - South Africa Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - South Africa Q4 2014BMI View: South Africa's tepid economic growth, depreciating currency and current account deficit willlimit the market potential ...
Pharmaceuticals and Healthcare Report - Serbia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Serbia Q4 2014BMI View: In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50%through a new ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceutical Industry Report - 2014 by Emerging Markets Direct Reports
Singapore Pharmaceutical Industry Report - 2014This report profiles Singapore’s pharmaceutical industry, analyzing sector size and performance, competitive landscape, recent development in the industry as well ...
Singapore Healthcare Industry 2H12 by Emerging Markets Direct Reports
Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
The Pharmaceutical Market: Singapore by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!